IMI - Call 17
The Innovative Medicines Initiative has published three future topics for their 17th call. The deadline is not announced yet.
The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry. IMI facilitates open collaboration in research to advance the development of, and accelerate patient access to, personalised medicines for the health and wellbeing of all, especially in areas of unmet medical need.
The following topics are under consideration for inclusion in the next IMI Call for proposals:
- Optimising future obesity treatment
- Open access chemogenomics library and chemical probes for the druggable genome
- Intelligent prediction and identification of environmental risks posed by human medicinal products
Link to IMI
The content of this article may still change dependent on changes in the final call.